Award-Winning Research Highlights the Growing Role of Artificial Intelligence and Virtual Patient Modeling in Personalized Cancer Care
As artificial intelligence continues to transform healthcare, physician–scientists who combine clinical expertise with advanced computational research are driving the future of precision medicine. Among them is Dr. Ohmini Krishnamurthy Rajendran, an Indian Consultant Radiologist, clinical researcher, author, and artificial intelligence researcher whose work spans precision oncology, computational medicine, medical imaging, digital health, and intelligent clinical decision-support systems.
In March 2026, Dr. Rajendran was honored with the National Award for Multidisciplinary Research and Innovation 2026 for her research paper, “Digital Twin Frameworks for Personalized Cancer Progression Modeling Using Longitudinal Data.” The award was presented at the Nehru Centre Auditorium, Mumbai, during a national ceremony recognizing excellence in scientific research, interdisciplinary innovation, and translational healthcare. The event brought together leading researchers, clinicians, academicians, healthcare innovators, and industry experts from across India.
The award recognizes research that advances scientific knowledge while demonstrating strong potential for real-world clinical impact. Dr. Rajendran’s work exemplifies this objective by exploring how artificial intelligence can enable more personalized, predictive, and data-driven approaches to cancer care.
Advancing Precision Oncology Through Digital Twin Technology
Cancer remains one of medicine’s most complex diseases, with every patient’s clinical course influenced by unique biological, genetic, and clinical characteristics. Although precision medicine has significantly improved cancer management, accurately predicting disease progression and selecting optimal treatment strategies continue to present major challenges.
Dr. Rajendran’s award-winning research addresses these challenges through a Digital Twin–based computational framework that creates dynamic virtual representations of individual cancer patients using longitudinal clinical data. Unlike conventional predictive models that provide static risk assessments, digital twins continuously evolve by incorporating new patient information throughout treatment, allowing clinicians to simulate disease progression and evaluate therapeutic strategies in a patient-specific setting.
The proposed framework integrates diverse healthcare data—including medical imaging, longitudinal clinical records, laboratory findings, genomic information, treatment history, and multimodal biomedical datasets—to develop intelligent virtual patient models capable of supporting personalized clinical decision-making.
Rather than focusing solely on algorithmic performance, the research emphasizes the development of clinically relevant computational infrastructure that can be integrated into routine oncology practice. By continuously updating virtual patient models as new clinical information becomes available, digital twin ecosystems have the potential to support physicians in anticipating disease trajectories, optimizing treatment strategies, monitoring therapeutic response, and delivering increasingly individualized cancer care.
Importantly, the study represents an emerging contribution toward translating digital twin concepts into clinically deployable decision-support systems, bridging advanced artificial intelligence with real-world oncology practice. This translational approach aligns with the broader evolution of healthcare toward predictive, preventive, personalized, and precision medicine.
Why the Research Was Recognized
The scientific evaluation committee acknowledged the publication for its strong clinical relevance, interdisciplinary innovation, patient-centered perspective, and potential to advance precision oncology through intelligent computational technologies.
The research highlights the convergence of radiology, artificial intelligence, computational oncology, digital health, longitudinal data science, and precision medicine. As AI-enabled clinical decision-support systems become increasingly integrated into healthcare, research that successfully combines advanced computational methods with practical clinical applications is expected to play a central role in future medical innovation.
The publication also contributes to the broader vision of intelligent healthcare ecosystems, where radiological imaging, pathology, genomics, laboratory investigations, electronic health records, treatment history, and continuous patient monitoring are integrated into unified computational platforms that support clinicians throughout the continuum of care.
By demonstrating how digital twin technologies may improve treatment planning, disease monitoring, personalized therapeutic decision-making, and adaptive cancer management, Dr. Rajendran’s work advances this vision. The research has also attracted growing interest among investigators working in computational oncology, digital twin technologies, precision medicine, radiology, artificial intelligence, and predictive healthcare, reflecting increasing international recognition of clinically applicable virtual patient modeling.
Bridging Clinical Practice and Artificial Intelligence Research
The award further strengthens Dr. Rajendran’s reputation as a physician–scientist working at the intersection of radiology, artificial intelligence, computational oncology, and precision healthcare.
Her research portfolio spans several emerging disciplines, including digital twin technologies, radiogenomics, computational pathology, multimodal cancer intelligence systems, explainable artificial intelligence, federated learning, foundation models, digital health technologies, predictive healthcare analytics, and translational medicine. Across these areas, her work is unified by the objective of developing intelligent computational frameworks that improve diagnostic accuracy, predict disease progression, optimize treatment planning, and ultimately support better patient outcomes through data-driven precision medicine.
Alongside her research, Dr. Rajendran continues to practice as a Consultant Radiologist, providing valuable frontline clinical experience that informs her scientific investigations. This integration of clinical practice with computational research enables her to identify clinically relevant challenges and develop practical, patient-centered technological solutions. Her multidisciplinary approach positions artificial intelligence not as a replacement for physician expertise but as a clinically meaningful tool that complements and enhances medical decision-making.
Leadership in the Scientific Community
Beyond her clinical and research contributions, Dr. Rajendran has established an expanding international academic presence through scientific publications, peer-review activities, editorial appointments, conference leadership, invited lectures, keynote presentations, and session chair responsibilities.
These engagements reflect growing recognition of her expertise within the global scientific community and underscore her contributions to advancing interdisciplinary research at the interface of medicine and artificial intelligence. Her expanding body of work illustrates the increasingly important role physician–scientists play in translating emerging computational technologies into clinically meaningful innovations while helping shape the future of intelligent healthcare.
Shaping the Future of Personalized Cancer Care
The significance of Dr. Rajendran’s research extends beyond a single award-winning publication. It reflects one of the most significant transformations underway in medicine—the shift from reactive healthcare toward predictive, preventive, personalized, and data-driven care.
As artificial intelligence becomes increasingly integrated into clinical practice, digital twins, multimodal analytics, and intelligent decision-support systems are expected to become integral components of next-generation oncology. Research such as Dr. Rajendran’s helps establish the scientific foundation for these future healthcare systems.
The National Award for Multidisciplinary Research and Innovation 2026 therefore recognizes more than an individual scientific achievement. It highlights the growing importance of interdisciplinary physician-led innovation in advancing healthcare and underscores the expanding contribution of Indian researchers to globally relevant scientific progress.
As precision medicine continues to evolve, physician–scientists capable of integrating clinical expertise with computational intelligence will play an increasingly important role in shaping the future of patient care. Through her contributions to digital twin technologies, computational oncology, precision medicine, artificial intelligence, and intelligent clinical decision-support systems, Dr. Ohmini Krishnamurthy Rajendran continues to contribute to this rapidly evolving field. Her recognition through the National Award for Multidisciplinary Research and Innovation 2026 reflects the growing impact of her scientific work and reinforces her role in advancing intelligent, data-driven virtual patient technologies with the potential to transform precision oncology and redefine the future of personalized cancer care.
About the Author
